Bradley Fikes reports for the San Diego Union-Tribune that San Diego’s Mapp Biopharmaceutical, developer of an antibody therapy for Ebola, has received a $14.8 million federal contract to develop a similar treatment for the related Sudan virus. Mapp Bio has options...